149 related articles for article (PubMed ID: 11191069)
1. Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: a dynamic balance.
Volpert OV
Cancer Metastasis Rev; 2000; 19(1-2):87-92. PubMed ID: 11191069
[TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.
Jiménez B; Volpert OV; Reiher F; Chang L; Muñoz A; Karin M; Bouck N
Oncogene; 2001 Jun; 20(26):3443-8. PubMed ID: 11423995
[TBL] [Abstract][Full Text] [Related]
3. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.
Jiménez B; Volpert OV; Crawford SE; Febbraio M; Silverstein RL; Bouck N
Nat Med; 2000 Jan; 6(1):41-8. PubMed ID: 10613822
[TBL] [Abstract][Full Text] [Related]
4. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor.
Volpert OV; Zaichuk T; Zhou W; Reiher F; Ferguson TA; Stuart PM; Amin M; Bouck NP
Nat Med; 2002 Apr; 8(4):349-57. PubMed ID: 11927940
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway.
Nör JE; Mitra RS; Sutorik MM; Mooney DJ; Castle VP; Polverini PJ
J Vasc Res; 2000; 37(3):209-18. PubMed ID: 10859480
[TBL] [Abstract][Full Text] [Related]
7. Regulation of endothelial cell survival and apoptosis during angiogenesis.
Chavakis E; Dimmeler S
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):887-93. PubMed ID: 12067894
[TBL] [Abstract][Full Text] [Related]
8. Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo.
Calzada MJ; Zhou L; Sipes JM; Zhang J; Krutzsch HC; Iruela-Arispe ML; Annis DS; Mosher DF; Roberts DD
Circ Res; 2004 Mar; 94(4):462-70. PubMed ID: 14699013
[TBL] [Abstract][Full Text] [Related]
9. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-5 and fluvastatin promote angiogenesis and are protective against endothelial cell apoptosis.
Muqri F; Helkin A; Maier KG; Gahtan V
J Cell Biochem; 2020 Oct; 121(10):4154-4165. PubMed ID: 32348623
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiogenesis by thrombospondin-2.
Volpert OV; Tolsma SS; Pellerin S; Feige JJ; Chen H; Mosher DF; Bouck N
Biochem Biophys Res Commun; 1995 Dec; 217(1):326-32. PubMed ID: 8526929
[TBL] [Abstract][Full Text] [Related]
13. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression.
Dardik R; Solomon A; Loscalzo J; Eskaraev R; Bialik A; Goldberg I; Schiby G; Inbal A
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1472-7. PubMed ID: 12805075
[TBL] [Abstract][Full Text] [Related]
14. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
15. The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent.
Addison CL; Nör JE; Zhao H; Linn SA; Polverini PJ; Delaney CE
BMC Cell Biol; 2005 Oct; 6():38. PubMed ID: 16262896
[TBL] [Abstract][Full Text] [Related]
16. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.
Simantov R; Febbraio M; Crombie R; Asch AS; Nachman RL; Silverstein RL
J Clin Invest; 2001 Jan; 107(1):45-52. PubMed ID: 11134179
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1.
Kang JH; Kim SA; Chang SY; Hong S; Hong KJ
Exp Mol Med; 2007 Jun; 39(3):402-11. PubMed ID: 17603295
[TBL] [Abstract][Full Text] [Related]
18. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis: a dynamic balance of stimulators and inhibitors.
Iruela-Arispe ML; Dvorak HF
Thromb Haemost; 1997 Jul; 78(1):672-7. PubMed ID: 9198237
[TBL] [Abstract][Full Text] [Related]
20. Perillyl alcohol is an angiogenesis inhibitor.
Loutrari H; Hatziapostolou M; Skouridou V; Papadimitriou E; Roussos C; Kolisis FN; Papapetropoulos A
J Pharmacol Exp Ther; 2004 Nov; 311(2):568-75. PubMed ID: 15210838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
